Cargando…

Approaching the immunophysiology of steroid resistance

Wang and colleagues have investigated a mechanistic basis for resistance to steroid therapy in systemic lupus erythematosus patients. Their examination reveals significant differences in macrophage migration inhibitory factor (MIF)-dependent expression of IκB, which is a critical cellular regulator...

Descripción completa

Detalles Bibliográficos
Autor principal: Bucala, Rick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446475/
https://www.ncbi.nlm.nih.gov/pubmed/22640701
http://dx.doi.org/10.1186/ar3820
_version_ 1782243984576348160
author Bucala, Rick
author_facet Bucala, Rick
author_sort Bucala, Rick
collection PubMed
description Wang and colleagues have investigated a mechanistic basis for resistance to steroid therapy in systemic lupus erythematosus patients. Their examination reveals significant differences in macrophage migration inhibitory factor (MIF)-dependent expression of IκB, which is a critical cellular regulator of the broadly proinflammatory transcription factor NF-κB. Their studies also suggest that MIF may be a clinically useful biomarker in systemic lupus erythematosus and support the therapeutic targeting of MIF as a means to reduce clinical steroid resistance.
format Online
Article
Text
id pubmed-3446475
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34464752012-11-18 Approaching the immunophysiology of steroid resistance Bucala, Rick Arthritis Res Ther Editorial Wang and colleagues have investigated a mechanistic basis for resistance to steroid therapy in systemic lupus erythematosus patients. Their examination reveals significant differences in macrophage migration inhibitory factor (MIF)-dependent expression of IκB, which is a critical cellular regulator of the broadly proinflammatory transcription factor NF-κB. Their studies also suggest that MIF may be a clinically useful biomarker in systemic lupus erythematosus and support the therapeutic targeting of MIF as a means to reduce clinical steroid resistance. BioMed Central 2012 2012-05-18 /pmc/articles/PMC3446475/ /pubmed/22640701 http://dx.doi.org/10.1186/ar3820 Text en Copyright ©2012 BioMed Central Ltd
spellingShingle Editorial
Bucala, Rick
Approaching the immunophysiology of steroid resistance
title Approaching the immunophysiology of steroid resistance
title_full Approaching the immunophysiology of steroid resistance
title_fullStr Approaching the immunophysiology of steroid resistance
title_full_unstemmed Approaching the immunophysiology of steroid resistance
title_short Approaching the immunophysiology of steroid resistance
title_sort approaching the immunophysiology of steroid resistance
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446475/
https://www.ncbi.nlm.nih.gov/pubmed/22640701
http://dx.doi.org/10.1186/ar3820
work_keys_str_mv AT bucalarick approachingtheimmunophysiologyofsteroidresistance